Proteomics International Laboratories
Logotype for Proteomics International Laboratories Ltd

Proteomics International Laboratories (PIQ) investor relations material

Proteomics International Laboratories H1 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Proteomics International Laboratories Ltd
H1 2026 earnings summary24 Feb, 2026

Executive summary

  • Transitioned from development to early commercial execution, launching PromarkerⓇD and PromarkerⓇEso in Australia and establishing US reimbursement pricing for PromarkerⓇD effective January 2026.

  • Expanded regulated laboratory capabilities in Australia and the US, and strengthened global intellectual property, including new US and Canadian patents for PromarkerⓇEso.

  • Early commercial revenues generated from controlled market launches, with strategic focus on commercial execution, clinical validation, and reimbursement progress.

  • Leadership transition with appointment of new CEO and addition of an independent Non-Executive Director.

Financial highlights

  • Revenue and other income for the half-year ended 31 December 2025 was $868,749, down 10% year-over-year.

  • Total expenses increased 27% to $6,934,776 compared to the prior year period.

  • Net loss before income tax was $6,066,027, a 35% increase from the previous year.

  • Net cash outflow from operating activities was $950,221, a 21% improvement year-over-year.

  • Cash and cash equivalents at period end were $7,669,698, down from $11,036,820 at 30 June 2025.

Outlook and guidance

  • Priorities for FY26 H2 include advancing US distribution partnerships, progressing reimbursement and coverage for PromarkerⓇD, and launching PromarkerⓇEso in the US.

  • Focus on completing validation for PromarkerⓇEndo and evaluating commercial pathways for OxiDx.

  • Emphasis on cost control, risk management, and building commercial teams in core markets.

Explain DTC strategy suspension
Future funding strategy given cash position
PromarkerD US market access timeline?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Proteomics International Laboratories earnings date

Logotype for Proteomics International Laboratories Ltd
H2 202625 Aug, 2026
Proteomics International Laboratories
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Proteomics International Laboratories earnings date

Logotype for Proteomics International Laboratories Ltd
H2 202625 Aug, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Proteomics International Laboratories Ltd is an Australian life sciences company specializing in predictive diagnostics and analytical services based on proteomics, the study of proteins. The company develops diagnostic tests for chronic diseases, with a focus on its flagship product, PromarkerD, a predictive test for diabetic kidney disease. In addition to diagnostics, Proteomics International provides contract research services, including protein analysis, biomarker discovery, and pharmaceutical testing, supporting drug development and medical research. Proteomics International Laboratories Ltd is headquartered in Perth, Australia, and its shares are listed on the ASX.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage